09:50 EST Merck KGaA (MKGAY) in talks to buy SpringWorks Therapeutics (SWTX), Reuters reports
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWTX:
- SpringWorks Therapeutics trading halted, volatility trading pause
- SpringWorks should be bought on weakness, says JPMorgan
- TD sees ‘some disappointment’ with lack of SpringWorks Therapeutics M&A news
- SpringWorks Therapeutics Reports Strong 2024 Financial Results
- SpringWorks Therapeutics sees Q4 U.S. OGSIVEO net revenue $61.5M